FIELD: chemistry.
SUBSTANCE: invention relates to novel quinoline derivatives of formula or pharmaceutically acceptable salts thereof, where n equals 0 or 1; when n equals 0, then R1 is hydrogen or methyl, R2 is hydroxyl, and R3 is hydrogen; and when n equals 1, R1 is hydrogen, and one of R2 and R3 is hydroxyl, and the other of R2 and R3 is hydrogen. The invention also relates to specific compounds of formula (I) and a method of producing compounds of formula (I).
EFFECT: novel quinoline derivatives are obtained, having high P2X7 antagonist activity.
9 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
MELANOCORTIN-4 RECEPTOR AGONISTS | 2020 |
|
RU2786864C1 |
TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
NEW CATECHOLAMINE-BASED PRODRUGS FOR USE IN TREATMENT OF PARKINSON'S DISEASE | 2018 |
|
RU2806075C2 |
PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST P2X OF RECEPTOR AND FACTOR OF TUMOUR NECROSIS α | 2004 |
|
RU2350354C2 |
PRODRUG OF FLUORINE-CONTAINING AMINO ACID | 2013 |
|
RU2639868C1 |
PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST OF P2X-RECEPTOR AND NONSTEROID ANTIINFLAMMATORY MEDICAL PRODUCT | 2004 |
|
RU2338556C2 |
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | 2017 |
|
RU2747318C2 |
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | 2022 |
|
RU2803084C1 |
AMINOPYRIDINE DERIVATIVES AND APPLICATION THEREOF AS SELECTIVE ALK-2 INHIBITORS | 2017 |
|
RU2777979C2 |
Authors
Dates
2012-09-10—Published
2008-03-19—Filed